Revision as of 22:59, 14 February 2011 editRjwilmsi (talk | contribs)Extended confirmed users, Pending changes reviewers, Rollbackers932,193 editsm Journal cites:, added 1 PMIDs, completed 2 page ranges, using AWB (7584)← Previous edit | Revision as of 23:37, 19 April 2011 edit undoCheMoBot (talk | contribs)Bots141,565 edits Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEMBL_Ref', 'KEGG_Ref') per Chem/Drugbox validation (Next edit → | ||
Line 1: | Line 1: | ||
{{drugbox | {{drugbox | ||
| verifiedrevid = 413962947 | |||
| IUPAC_name = N-(4-(2-methoxyphenoxy)phenyl)- N-(2,2,2-trifluoroethylsulfonyl)pyrid- 3-ylmethylamine | | IUPAC_name = N-(4-(2-methoxyphenoxy)phenyl)- N-(2,2,2-trifluoroethylsulfonyl)pyrid- 3-ylmethylamine | ||
| image = LY-487,379_structure.png | | image = LY-487,379_structure.png |
Revision as of 23:37, 19 April 2011
Pharmaceutical compoundClinical data | |
---|---|
ATC code |
|
Identifiers | |
IUPAC name
| |
PubChem CID | |
IUPHAR/BPS | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C21H19F3N2O4S |
Molar mass | 452.446 g/mol g·mol |
3D model (JSmol) | |
SMILES
| |
(verify) |
LY-487,379 is a drug used in scientific research that acts as a selective positive allosteric modulator for the metabotropic glutamate receptor group II subtype mGluR2. It is used to study the structure and function of this receptor subtype, and LY-487,379 along with various other mGluR2/3 agonists and positive modulators are being investigated as possible antipsychotic and anxiolytic drugs.
See also
References
- Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 12852748, please use {{cite journal}} with
|pmid=12852748
instead. - Schaffhauser, H.; Rowe, B. A.; Morales, S.; Chavez-noriega, L. E.; Yin, R.; Jachec, C.; Rao, S. P.; Bain, G.; Pinkerton, A. B. (2003). "Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2". Molecular Pharmacology. 64 (4): 798–810. doi:10.1124/mol.64.4.798. PMID 14500736.
{{cite journal}}
:|first10=
missing|last10=
(help); More than one of|author2=
and|last2=
specified (help); More than one of|author3=
and|last3=
specified (help); More than one of|author4=
and|last4=
specified (help); More than one of|author5=
and|last5=
specified (help); More than one of|author6=
and|last6=
specified (help); More than one of|author7=
and|last7=
specified (help); More than one of|author8=
and|last8=
specified (help); More than one of|author9=
and|last9=
specified (help) - Poisik, O.; Raju, D. V.; Verreault, M.; Rodriguez, A.; Abeniyi, O. A.; Conn, P. J.; Smith, Y. (2005). "Metabotropic glutamate receptor 2 modulates excitatory synaptic transmission in the rat globus pallidus". Neuropharmacology. 49: 57–50. doi:10.1016/j.neuropharm.2005.03.006. PMID 15993439.
- Galici, R.; Echemendia, N. G.; Rodriguez, A. L.; Conn, P. J. (2005). "A Selective Allosteric Potentiator of Metabotropic Glutamate (mGlu) 2 Receptors Has Effects Similar to an Orthosteric mGlu2/3 Receptor Agonist in Mouse Models Predictive of Antipsychotic Activity". Journal of Pharmacology and Experimental Therapeutics. 315 (3): 1181–7. doi:10.1124/jpet.105.091074. PMID 16123306.
- Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 16368268, please use {{cite journal}} with
|pmid=16368268
instead. - Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 17318501, please use {{cite journal}} with
|pmid=17318501
instead. - Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 190790739, please use {{cite journal}} with
|pmid=190790739
instead.
This pharmacology-related article is a stub. You can help Misplaced Pages by expanding it. |